News

4 December 2024 The ADAMPA clinical trial supports patient self-management of blood pressure as a strategy to improve hypertension control The ADAMPA clinical trial provides evidence supporting patient self-management of blood pressure and, therefore, their empowerment as a strategy to improve hypertension control. This trial is the result of collaboration between the INCLIVA Health Research Institute at the Hospital Clínico Universitario de Valencia, the Foundation for the Promotion of Health and Biomedical Research of the Valencian Community (Fisabio), and the Carlos III Health Institute (ISCIII). Read more
27 september 2024 II Conference of the ISCIII Platforms for the Support of R&D&I in Biomedicine and Health Sciences From 28 to 30 October 2024, the city of Lleida will host the second edition of the ISCIII PLATFORMS TO SUPPORT R&D&I in BIOMEDICINE AND HEALTH SCIENCES, organised by the ISCIII Platform for Biomodels and Biobanks (P_ISCIII_BB), the ISCIII Platform for the Revitalisation and Innovation of the industrial capacities of the NHS and their effective transfer to the productive sector (ITEMAS) and the ISCIII Platform for the Support of Independent Clinical Research (SCReN); the ISCIII Platform for the Revitalisation and Innovation of the industrial capacities of the NHS and their effective transfer to the productive sector (ITEMAS), the ISCIII Platform for Dynamisation and Innovation of the industrial capacities of the NHS and their effective transfer to the productive sector (ITEMAS) and the ISCIII Platform for Independent Clinical Research Support (SCReN); hereinafter ‘ISCIII Platforms’. Registration open until 4 October 2024. Translated with DeepL.com (free version) Registration here
30 July 2024 Information on the Medicines Research Ethics Committees (IRBs) Following the entry into force of Royal Decree 1090/2015, of 4 December, which regulates clinical trials with medicinal products, the Ethics Committees for clinical trials with medicinal products, the Ethics Committees for Research with medicinal products and the Spanish Register of Spanish Register of Clinical Trials, the AEMPS is now responsible for the maintenance of the contents of this page in relation to the Research Ethics Committees. Read more
30 July 2024 The AEMPS implements a system that will allow clinical trial sponsors to know the availability of the the availability of the evaluation of the CEIm The Spanish Agency for Medicines and Health Products (AEMPS) has implemented a new system which the availability of the medicines research ethics committees (CEIm) to assess new applications for authorisation of clinical trials. (CEIm) to assess new applications for clinical trial authorisation. Read more
20th May 2024 INTERNATIONAL CLINICAL TRIALS DAY - 2024 From the UIC of the Hospital 12 de Octubre (i+12) belonging to SCReN they have made this beautiful publication that we share with you. Congratulations for the great work! Read more
15 January 2024 SIMPLIFY in The Lancet The Lancet, one of the highest impact journals in medical research, has published the final results of the study "Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial "Efficacy and safety of a structured de-escalation of anti-pseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): open-label, multicentre, randomised trialEfficacy and safety of a structured de-escalation of anti-pseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): open-label, multicentre, randomised trial". This study was managed by the IBIS UIC and involved 13 SCReN units.
29th December, 2023 Summary 2023 SCReN 31 December marks the end of the third stage of the Clinical Research Support Platform Independent Clinical Research Support Platform SCReN. We can think of no better way to end the year than with a brief summary of all the activities that have been all the activities that have been carried out to date and thanking all the units for their involvement and fundamental role during this period. involvement and fundamental role during this period. We wish you all a HAPPY 2024! Read more...
From 6th to 19th november, 2023 Science and Innovation Week This year we have been at the Complutense University of Madrid Faculty of Statistical Studies (UCM) 👉 The masked random superhero and his sidekick essay.
The teachers were:
Javier Bora Hernando (Statistical Technician at imas12).
Dr. María Jesús López Herrero (Professor at the Faculty of Statistical Studies and coordinator of the Master in Biostatistics - UCM).
Dr. David Lora Pablos
Los profesores fuimos:
Read more...
06th November, 2023 10th anniversary of the clinical research support platform SCReN The SCReN Platform was set up in 2013 with the aim of providing R&D&I centres in Health Sciences and Technologies with a scientific-technical support that the global development of clinical trials and observational studies in the academic environment, with the highest academic environment, with the highest methodological-technical rigour so that the evidence obtained is quickly applicable in clinical applicable in clinical practice in a rapid and efficient manner. Read more
24th October, 2023 BCN Dance your science On 21 November 2023, the staff of the IMIM-Hospital del Mar Unit will take part in a dance show at the Sant Andreu theatre to show students and the general public several dance show at the Sant Andreu theatre to inform students and the public about various research projects carried out at the research projects being carried out at the institution. Among the projects to be will be presented include the ICOD project, an international clinical trial involving people with people with Down's Syndrome, with the collaboration of volunteers with experience in theatre for its exhibition. theatre for its exhibition.
25th October, 2023 Nature Medicine Nature Medicine, one of the most influential journals in medical research, has published the final results of the SAFO study the final results of the SAFO study "A multicentre, randomised, open-label, phase III-IV, multicentre clinical trial to evaluate the III-IV clinical trial to evaluate the efficacy of cloxacillin and fosfomycin combination versus cloxacillin monotherapy in patients with cloxacillin monotherapy in patients with methicillin-sensitive Staphylococcus aureus bacteraemia". This study has been managed by the UIC of IDIBELL and has involved 7 units of SCReN. Read more